Unique ID issued by UMIN | UMIN000016251 |
---|---|
Receipt number | R000018862 |
Scientific Title | Efficacy and safety of a single-pill fix dose combination of azilsartan and amlodipine |
Date of disclosure of the study information | 2015/01/17 |
Last modified on | 2017/01/19 21:24:27 |
Efficacy and safety of a single-pill fix dose combination of azilsartan and amlodipine
4A study
Efficacy and safety of a single-pill fix dose combination of azilsartan and amlodipine
4A study
Japan |
Hypertension
Cardiology |
Others
NO
Combinations of angiotensin II type 1 receptor blockers (ARBs) and calcium channel blockers (CCBs) are recommended by various guidelines for the treatment of high blood pressure. Many kinds of single-pill fixed-dose combinations of ARBs and CCBs are available for clinical use in Japan. It is still controversial what types of single-pill fixed-dose combinations of ARBs and CCBs are useful. Therefore, we compared the efficacies and safety of single-pill fixed-dose combinations of ARBs and CCBs (azilsartan and amlodipine vs. valsartan and amlodipine or irbesartan and amlodipine).
Safety,Efficacy
Exploratory
Explanatory
Not applicable
Depressor effects at office blood pressure
1.The percentage of patients who reach the target office blood pressure.
2.Changes in biochemical parameters in blood and urine.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Medicine |
The patients receive a single-pill fixed-dose combination of a single-pill fixed-dose combination of azilsartan/amlodipine and treated for 16 weeks. If the patient dose not reach the target office blood pressure at 8 weeks according to Japanese Society of Hypertension Guideline 2014, they received double doses of amlodipine.
The patients receive a single-pill fixed-dose combination of valsartan/amlodipine or irbesartan/amlodipine and treated for 16 weeks. If the patient dose not reach the target office blood pressure at 8 weeks according to Japanese Society of Hypertension Guideline 2014, they received double doses of amlodipine.
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients with hypertension who receive a single-pill fixed-dose combination of valsartan/amlodipine or irbesartan/amlodipine
2.Age is 20 years old or more.
3.Patients who give their informed consent to participate for the present study.
1.Severe liver dysfunction.
2.Severe renal dysfunction.
3.Pregnancy or lactation in women.
4.Patients with a history of allergy to any component of the study medications.
5.Patients corresponding to the contraindication of study medications.
6.Ineligible patients according to the judgment by physician.
40
1st name | |
Middle name | |
Last name | Keijiro Saku |
Fukuoka University School of Medicine
Department of Cardiology
7-45-1 Nanakuma, Jonan-Ku, Fukuoka.
81-92-801-1011
saku-k@fukuoka-u.ac.jp
1st name | |
Middle name | |
Last name | Shin-ichiro Miura |
Fukuoka University School of Medicine
Department of Cardiology
7-45-1 Nanakuma, Jonan-Ku, Fukuoka.
81-92-801-1011
miuras@cis.fukuoka-u.ac.jp
Department of Cardiology, Fukuoka University School of Medicine
Department of Cardiology, Fukuoka University School of Medicine
Self funding
Japan
NO
福岡大学病院(福岡県)、井上病院(福岡県)、藤沢内科(福岡県)、松永病院(福岡県)、城谷病院(福岡県)、出水総合医療センター(鹿児島県)
2015 | Year | 01 | Month | 17 | Day |
Published
Completed
2014 | Year | 05 | Month | 30 | Day |
2014 | Year | 07 | Month | 01 | Day |
2016 | Year | 03 | Month | 30 | Day |
2016 | Year | 07 | Month | 30 | Day |
2016 | Year | 07 | Month | 30 | Day |
2016 | Year | 08 | Month | 29 | Day |
2015 | Year | 01 | Month | 17 | Day |
2017 | Year | 01 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018862